Abu Dhabi Receives AstraZeneca’s COVID-19 Antibody Drug Evusheld
- Publish date: Thursday، 06 January 2022 Reading time: 1 min read
- Related articles
- Jazan Border Guards Stop the Smuggling of 90kg of Narcotic Qat
- Khamzat Chimaev Speaks Out After UFC Saudi Arabia Withdrawal
- Saudia to Resume Flights to Dubai, Abu Dhabi, and Amman from This Date
Abu Dhabi has received the first global shipment of AstraZeneca’s COVID-19 long-acting antibody medication, Evusheld, after gaining emergency use authorisation from the UAE’s Ministry of Health and Prevention.
فيديو ذات صلة
This browser does not support the video element.
Evusheld, is designed to prevent severe infection and death amongst immunocompromised patients.
Read More: Worship places in Abu Dhabi
Read More: Abu Dhabi Entry Requirements Update
Read More: December Prayer Times In Abu Dhabi
The first doses of Evusheld arrived in Abu Dhabi on Monday following a collaboration of key partners including Rafed, the UAE’s Primary Group Purchasing Organisation, along with Etihad Cargo, AstraZeneca and Abu Dhabi Airports Company.
.@DoHSocial has received the first global shipment of AstraZeneca’s Evusheild (formerly AZD7442), a medication to protect immunocompromised patients against Covid-19. pic.twitter.com/RHf61XcmMU
— مكتب أبوظبي الإعلامي (@admediaoffice) December 20, 2021
The breakthrough medication will be stored at Rafed’s distribution centre to be transported to various destinations.
This article was previously published on UAE Moments.To see the original article, click here